| 2015 | Upregulated, 7q21-22 amplicon candidate gene SHFM1 confers oncogenic advantage by suppressing p53 function in gastric cancer | CELLULAR SIGNALLING |
| 2015 | Caregiving burden and the quality of life of family caregivers of cancer patients: the relationship and correlates | EUROPEAN JOURNAL OF ONCOLOGY NURSING |
| 2015 | Phase II study of trastuzumab in combination with S-1 and cisplatin in the first-line treatment of human epidermal growth factor receptor HER2-positive advanced gastric cancer | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2015 | Clinicopathological features and prognostic significance of HER2 expression in gastric cancer | ONCOLOGY |
| 2015 | Low-concentration vemurafenib induces the proliferation and invasion of human HaCaT keratinocytes through mitogen-activated protein kinase pathway activation | JOURNAL OF DERMATOLOGY |
| 2015 | Institutional Board Review for Clinical Investigations on Inflammatory Bowel Diseases: A Single-Center Study
| INTESTINAL RESEARCH |
| 2015 | Efficacy of pazopanib monotherapy in patients who had been heavily pretreated for metastatic soft tissue sarcoma: a retrospective case series
| BMC CANCER |
| 2015 | Pain palliation in patients with bone metastases using magnetic resonance-guided focused ultrasound with conformal bone system: a preliminary report.
| YONSEI MEDICAL JOURNAL |
| 2015 | Dovitinib (TKI258), a multi-target angiokinase inhibitor, is effective regardless of KRAS or BRAF mutation status in colorectal cancer
| AMERICAN JOURNAL OF CANCER RESEARCH |
| 2015 | PINCH-2 presents functional copy number variation and suppresses migration of colon cancer cells by paracrine activity | INTERNATIONAL JOURNAL OF CANCER |
| 2015 | Neoadjuvant chemoradiotherapy followed by D2 gastrectomy in locally advanced gastric cancer
| WORLD JOURNAL OF GASTROENTEROLOGY |
| 2015 | Incidence and Survival of Pediatric Soft Tissue Sarcomas: Comparison between Adults and Children
| CANCER RESEARCH AND TREATMENT |
| 2015 | Proper timing of adjuvant chemotherapy affects survival in patients with stage 2 and 3 gastric cancer | ANNALS OF SURGICAL ONCOLOGY |
| 2015 | PTEN deficiency as a predictive biomarker of resistance to HER2-targeted therapy in advanced gastric cancer | ONCOLOGY |
| 2014 | Survival outcome and treatment response of patients with late relapse from renal cell carcinoma in the era of targeted therapy. | EUROPEAN UROLOGY |
| 2014 | Impact of bone and liver metastases on patients with renal cell carcinoma treated with targeted therapy.
| EUROPEAN UROLOGY |
| 2014 | The impact of low serum sodium on treatment outcome of targeted therapy in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Cancer Database Consortium.
| EUROPEAN UROLOGY |
| 2014 | The metalloprotease ADAMTS8 displays antitumor properties through antagonizing EGFR-MEK-ERK signaling and is silenced in carcinomas by CpG methylation.
| MOLECULAR CANCER RESEARCH |
| 2014 | The effect of disintegrin-metalloproteinase ADAM9 in gastric cancer progression. | MOLECULAR CANCER THERAPEUTICS |
| 2014 | First-line Mammalian target of rapamycin inhibition in metastatic renal cell carcinoma: an analysis of practice patterns from the International Metastatic Renal Cell Carcinoma Database Consortium.
| CLINICAL GENITOURINARY CANCER |
| 2014 | A population-based overview of sequences of targeted therapy in metastatic renal cell carcinoma. | CLINICAL GENITOURINARY CANCER |
| 2014 | Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials
| ANNALS OF ONCOLOGY |
| 2014 | Angiogenesis inhibitor therapies for advanced renal cell carcinoma: toxicity and treatment patterns in clinical practice from a global medical chart review
| INTERNATIONAL JOURNAL OF ONCOLOGY |
| 2014 | Anti-VEGF therapy in mRCC: differences between Asian and non-Asian patients.
| BRITISH JOURNAL OF CANCER |
| 2014 | Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial. | LANCET ONCOLOGY |
| 2014 | First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC.
| BRITISH JOURNAL OF CANCER |
| 2014 | Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium. | EUROPEAN UROLOGY |
| 2014 | A phase IIa dose-finding and safety study of first-line pertuzumab in combination with trastuzumab, capecitabine and cisplatin in patients with HER2-positive advanced gastric cancer.
| BRITISH JOURNAL OF CANCER |
| 2014 | Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma with renal insufficiency | EUROPEAN JOURNAL OF CANCER |
| 2014 | Clinical Features and Treatment of Collecting Duct Carcinoma of the Kidney from the Korean Cancer Study Group Genitourinary and Gynecology Cancer Committee
| CANCER RESEARCH AND TREATMENT |
| 2014 | Kaposi's Varicelliform-Like Eruption in a Patient Treated with Everolimus for Metastatic Renal Cell Carcinoma: Report of a Rare Case.
| CASE REPORTS IN ONCOLOGY |
| 2014 | Phase II Randomized Trial Comparing Sequential First-Line Everolimus and Second-Line Sunitinib Versus First-Line Sunitinib and Second-Line Everolimus in Patients With Metastatic Renal Cell Carcinoma | JOURNAL OF CLINICAL ONCOLOGY |
| 2014 | Phase II gemcitabine and capecitabine combination therapy in recurrent or metastatic breast cancer patients pretreated with anthracycline and taxane | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2014 | High KLF4 level in normal tissue predicts poor survival in colorectal cancer patients
| WORLD JOURNAL OF SURGICAL ONCOLOGY |
| 2014 | Comparison of Melanoma Subtypes among Korean Patients by Morphologic Features and Ultraviolet Exposure
| ANNALS OF DERMATOLOGY |
| 2014 | Angiogenic factor thymidine phosphorylase associates with angiogenesis and lymphangiogenesis in the intestinal-type gastric cancer | PATHOLOGY |
| 2014 | Ifosfamide-induced Fanconi syndrome with diabetes insipidus
| KOREAN JOURNAL OF INTERNAL MEDICINE |
| 2014 | Vascular Soft-Tissue Sarcomas: A Prognostic Model from a Retrospective Single-Center Study | ONCOLOGY |
| 2014 | Tumor perfusion-related parameter of diffusion-weighted magnetic resonance imaging: Correlation with histological microvessel density | MAGNETIC RESONANCE IN MEDICINE |
| 2014 | Prognostic implications of anaplastic lymphoma kinase gene aberrations in rhabdomyosarcoma; an immunohistochemical and fluorescence in situ hybridisation study | JOURNAL OF CLINICAL PATHOLOGY |
| 2013 | Multicenter phase II study of everolimus in patients with metastatic or recurrent bone and soft-tissue sarcomas after failure of anthracycline and ifosfamide | INVESTIGATIONAL NEW DRUGS |
| 2013 | Metastatic non–clear cell renal cell carcinoma treated with targeted therapy agents: Characterization of survival outcome and application of the International mRCC Database Consortium criteria | CANCER |
| 2013 | PIK3CA Mutations in Hepatocellular Carcinoma in Korea
| YONSEI MEDICAL JOURNAL |
| 2013 | Efficacy and safety of everolimus in Korean patients with metastatic renal cell carcinoma | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2013 | Pharmacogenetic determinants associated with sunitinib-induced toxicity and ethnic difference in Korean metastatic renal cell carcinoma patients | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2013 | Defining the target volume for post-operative radiotherapy after D2 dissection in gastric cancer by CT-based vessel-guided delineation | RADIOTHERAPY AND ONCOLOGY |
| 2013 | Pharmacogenomic Assessment of Outcomes of Pemetrexed-Treated Patients with Adenocarcinoma of the Lung
| YONSEI MEDICAL JOURNAL |
| 2013 | Changing treatment patterns in elderly patients with resectable colon cancer | ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY |
| 2013 | Combination of CYP inhibitor with MEK/ERK inhibitor enhances the inhibitory effect on ERK in BRAF mutant colon cancer cells. | ANTICANCER RESEARCH |
| 2013 | Randomized controlled trial of standardized education and telemonitoring for pain in outpatients with advanced solid tumors
| SUPPORTIVE CARE IN CANCER |
http://orcid.org/0000-0002-2512-4531
(7006023235)
